| Literature DB >> 34976659 |
Dusan Petrovic1,2,3, Kailing Marcus1, José Sandoval4, Stéphane Cullati5,6, Giovanni Piumatti7, Patrick Bodenmann8,9, Yves-Laurent Jackson1, Claire Durosier Izart1, Hans Wolff1, Idris Guessous1, Silvia Stringhini1,2.
Abstract
Forgoing healthcare for economic reasons has been previously associated with adverse health outcomes, including a higher risk of hospitalization, a lower quality of life, and worse self-reported health. However, the exact cause-to-effect relation between forgoing healthcare and health-related outcomes has been insufficiently described. Here, we investigate the prospective health consequences of forgoing healthcare for economic reasons using data from "ReBus" (N = 400), a prospective study examining the health consequences of forgoing healthcare (Baseline: 2008-2013, Follow-up: 2014-2016). Using regression models, we explored the baseline determinants of forgoing healthcare, including socioeconomic, demographic, and pre-existing health-risk factors, and examined the associations between forgoing healthcare at baseline and health deterioration at follow-up, using highly pertinent biomarkers (glucose, glycated hemoglobin, lipids, blood pressure) and SF-36 questionnaire data. Low income, low occupation, low education, and smoking were associated with higher odds of forgoing healthcare at baseline. Forgoing healthcare for economic reasons at baseline was subsequently related to detrimental changes in glucose, high-density lipoprotein cholesterol (HDL), and blood pressure (BP) at follow-up, independently of baseline socioeconomic factors (Glucose-β = 0.19, 95%CI[0.03;0.34], HDL-β = -0.07, 95%CI[-0.14;0.01], BP-β = 3.30, 95%CI[-0.01;6.60]). Moreover, we found strong associations between forgoing healthcare and adverse SF-36 health scores at follow-up, with individuals forgoing healthcare systematically displaying worse health scores (6%-11% lower scores). For the first time, we show that forgoing healthcare for economic reasons predicts adverse health-related consequences 2-8 years later. Our findings shall further encourage the implementation of public health measures aimed at identifying individuals who forgo healthcare and preventing the adverse health consequences of unmet medical needs.Entities:
Keywords: Blood biomarkers; Forgoing healthcare; Health consequences; SF-36; Self-reported health; Socioeconomic determinants; Switzerland
Year: 2021 PMID: 34976659 PMCID: PMC8683898 DOI: 10.1016/j.pmedr.2021.101602
Source DB: PubMed Journal: Prev Med Rep ISSN: 2211-3355
Baseline characteristics of included “ReBus” participants (Baseline: 2008–2013, N = 400).
| Not forgoing healthcare (N = 228) | Forgoing healthcare (N = 172) | ||
|---|---|---|---|
| 125 (55%) | 96 (56%) | 0.844 | |
| 164 (74%) | 114 (69%) | 0.301 | |
| 49.6 (±10) | 45.8 (±11.5) | 0.002 | |
| 55.2 (±10) | 50.8 (±11.8) | <0.001 | |
| High | 101 (45%) | 57 (34%) | 0.044 |
| Middle | 61 (27%) | 47 (28%) | |
| Low | 62 (28%) | 64 (38%) | |
| High | 56 (29%) | 19 (15%) | 0.013 |
| Middle | 71 (37%) | 54 (43%) | |
| Low | 65 (34%) | 54 (43%) | |
| >13000 CHF | 56 (25%) | 10 (6%) | <0.001 |
| 9500–13000 CHF | 49 (22%) | 22 (14%) | |
| 7000–9500 CHF | 55 (25%) | 37 (23%) | |
| 5000–7000 CHF | 26 (12%) | 33 (21%) | |
| 3000–5000 CHF | 26 (12%) | 42 (26%) | |
| <3000 CHF | 8 (4%) | 15 (9%) | |
| 300–500 CHF | 120 (54%) | 88 (53%) | 0.079 |
| 1000–1500 CHF | 66 (29%) | 37 (22%) | |
| 2000–2500 CHF | 38 (17%) | 42 (25%) | |
| 42 (19%) | 49 (28%) | 0.019 | |
| Hypertension | 56 (25%) | 42 (24%) | 0.974 |
| Diabetes | 8 (4%) | 8 (5%) | 0.564 |
| High cholesterol | 49 (21%) | 42 (24%) | 0.489 |
| Anti-hypertension medication | 29 (13%) | 13 (8%) | 0.096 |
| Anti-diabetes medication | 3 (1%) | 3 (2%) | 0.727 |
| Anti-cholesterol medication | 15 (7%) | 12 (7%) | 0.875 |
| Excellent | 33 (29%) | 16 (14%) | 0.008 |
| Very good | 63 (56%) | 62 (55%) | |
| Good | 13 (12%) | 28 (25%) | |
| Fair | 3 (3%) | 5 (4%) | |
| Poor | 0 (0%) | 2 (2%) | |
| Surgery | 21 (13%) | ||
| General practitioner consultation | 48 (29%) | ||
| Specialist consultation | 81 (49%) | ||
| Medication | 39 (23%) | ||
| Dental care | 99 (59%) | ||
| Re-adaptation in hospital | 1 (0.6%) | ||
| Ambulatory re-adaptation | 3 (2%) | ||
| Devices | 79 (47%) | ||
| Care in medical center | 5 (3%) | ||
| Home care | 4 (2%) | ||
| Home assistance | 7 (4%) | ||
| Any other type of healthcare | 19 (11%) | ||
Data are mean ± SD for continuous variables and n (%) for categorical variables.
The Mann-Whitney U test was performed for continuous variables (age at baseline, age at follow-up).
The χ2 test was performed for categorical variables.
Association between demographic, socioeconomic, and health-related risk factors and forgoing healthcare at baseline (Baseline: 2008–2013, N = 400).
| Demographic/socioeconomic factors | OR [95%CI] | N | |
|---|---|---|---|
| Swiss origin | 0.82 [0.52; 1.30] | 0.403 | 387 |
| Education (LH) | 2.04 [1.25; 3.33] | 0.005 | 392 |
| Occupational position (LH) | 2.16 [1.16; 4.02] | 0.015 | 319 |
| Household income adj. (Tertiles-LH) | 5.32 [3.01; 9.39] | <0.001 | 379 |
| Deductibles (LH) | 1.07 [0.63; 1.83] | 0.806 | 391 |
| Smoking | 1.71 [1.06; 2.76] | 0.029 | 399 |
| Hypertension | 1.28 [0.78; 2.09] | 0.325 | 400 |
| Diabetes | 1.61 [0.58; 4.46] | 0.358 | 400 |
| High cholesterol | 1.64 [0.98; 2.74] | 0.058 | 400 |
| Anti-hypertension medication | 0.83 [0.40; 1.74] | 0.628 | 400 |
| Anti-diabetes medication | 1.65 [0.32; 8.51] | 0.551 | 400 |
| Anti-cholesterol medication | 1.61 [0.70; 3.73] | 0.265 | 400 |
| Self-reported health (LH) | 3.33 [1.09; 5.56] | 0.005 | 398 |
OR, odds ratio; CI, confidence interval; LH, lowest vs. highest category cardiovascular disorders, and medication intake at baseline).
Logistic regression for the association between demographic, socioeconomic, and health-related risk factors (predictors) and forgoing healthcare (outcome), adjusting for sex and age at baseline.
Income adjusted for household composition (OECD-modified scale formula) - Tertiles: lowest vs. highest.
Self-reported health was imputed (N = 20 imputations, 45% missing values) based on sex, age, self-reported hypercholesterolemia, diabetes, high blood pressure.
Fig. 1Association between forgoing healthcare at baseline and difference in blood biomarkers and arterial blood pressure between follow-up and baseline (Baseline: 2008–2013 - Follow-up: 2014–2016, N = 400) β, linear regression coefficient; CI, confidence interval; Glu, glucose; TChol, total cholesterol, TG, triglycerides, HDL, HDL cholesterol; Hba1c, glycated hemoglobin; TAmax, maximum average blood pressure difference, TAmin, minimum average BP difference, CMD, cardiometabolic disorders M1: Linear regression for the association between forgoing healthcare and biomarkers change (follow-up - baseline), adjusting for sex, age at baseline, age at follow-up, education, occupational position, and income (Table 2) M2: Linear regression for the association between forgoing healthcare and biomarkers change (follow-up - baseline), additionally adjusted for baseline hypercholesterolemia, high blood pressure, diabetes status and related medication intake at baseline (anti-hypertension drugs, anti-diabetes drugs, anti-cholesterol).
Fig. 2Association between forgoing healthcare at baseline and SF-36 health scores at follow-up (Baseline: 2008–2013 - Follow-up: 2014–2016, N = 400) β, linear regression coefficient; CI, confidence interval; PF, physical functioning; RPh, role-physical; Pain, bodily pain; GenH, general health; Vit, vitality; Soc, social functioning; Em, role-emotional; MH, mental health; HTr, health transition M1: Linear regression for the association between forgoing healthcare at baseline and SF-36 health scores, adjusting for sex, age at baseline, age at follow-up, education, occupational position, income, and smoking M2: Linear regression for the association between forgoing healthcare at baseline and SF-36 health scores, additionally adjusted for baseline self-reported health (N = 20 imputations, 45% missing values – imputation based on sex, age, self-reported hypercholesterolemia, diabetes, high blood pressure, and cardiovascular disorders at baseline.